0000000000323954

AUTHOR

Yvonne Serfert

showing 4 related works from this author

DHCR_OST-Cannabis_Alcohol_supplementary_2018-10-30_xyz151015746ed84_3-converted – Supplemental material for Alcohol and Cannabis Consumption Does Not…

2019

Supplemental material, DHCR_OST-Cannabis_Alcohol_supplementary_2018-10-30_xyz151015746ed84_3-converted for Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy—Data From the German Hepatitis C-Registry (DHC-R) by Stefan Christensen, Peter Buggisch, Stefan Mauss, Klaus HW Böker, Tobias Müller, Hartwig Klinker, Tim Zimmermann, Yvonne Serfert, Bernd Weber, Jens Reimer and Heiner Wedemeyer in Substance Abuse: Research and Treatment

111799 Public Health and Health Services not elsewhere classifiedFOS: Health sciences
researchProduct

Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substit…

2019

Background: The importance of alcohol and cannabis consumption for the effectiveness of treatment of chronic hepatitis C virus (HCV) infection with direct acting antivirals (DAAs) in people on opioid substitution therapy (OST) has not been investigated in detail. Methods: We investigated sustained virological response (SVR) rates and proportion of lost to follow-up (LTFU) between OST (n = 739) and non-OST patients (n = 7008) in the German Hepatitis C-Registry (Deutsches Hepatitis C-Register, DHC-R), which is a national multicenter prospective non-interventional real-world registry. Non-OST patients comprised patients with former/current drug use (non-OST/DU; n = 1500) and patients never con…

cannabismedicine.medical_specialtyMedizinShort ReportAlcoholVirus03 medical and health scienceschemistry.chemical_compound0302 clinical medicineChronic hepatitisInternal medicinereal-world settingmedicine030212 general & internal medicinePWIDConsumption (economics)biologyOSTbusiness.industryalcohollcsh:Public aspects of medicinefungilcsh:RA1-1270Hepatitis Cbiology.organism_classificationmedicine.diseaseSVR12Psychiatry and Mental healthchemistryCohortHCV030211 gastroenterology & hepatologyCannabisbusinessOpioid substitution therapySubstance abuse : research and treatment
researchProduct

IMPACT OF DIRECT-ACTING ANTIVIRAL THERAPY ON THE NEED FOR LIVER TRANSPLANTATION RELATED TO HEPATITIS C IN GERMANY

2018

Hepatologybiologybusiness.industryHepacivirusmedicine.medical_treatmentMedizinAntiviral therapyHepacivirusHepatitis CHepatitis C ChronicLiver transplantationbiology.organism_classificationmedicine.diseaseAntiviral AgentsLiver Transplantation03 medical and health sciences0302 clinical medicineGermany030220 oncology & carcinogenesisImmunologymedicineHumans030211 gastroenterology & hepatologybusinessDirect acting
researchProduct

Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: Still a concern in clinical practice?

2018

BACKGROUND AND AIMS There is limited real-world information on the effectiveness of antiviral treatment of chronic hepatitis C virus (HCV) infection with direct-acting antivirals (DAA) in people on opioid substitution therapy (OST). This study compared sustained virological response (SVR) rates and proportion of lost to follow-up (LTFU) between OST and non-OST patients in the German Hepatitis C-Registry (DHC-R). DESIGN National multi-centre prospective real-world registry (German Hepatitis C-Registry, DHC-R). Non-OST patients comprised patients with former/current drug use (non-OST/DU) and patients never consuming drugs (non-OST/NDU). SETTING A total of 254 medical centres in Germany, inclu…

HepatitisDrugeducation.field_of_studymedicine.medical_specialtyCirrhosisbusiness.industrymedia_common.quotation_subjectfungiPopulationMedicine (miscellaneous)medicine.diseaseClinical Practice03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineInternal medicineMedicine030211 gastroenterology & hepatology030212 general & internal medicineAntiviral treatmentbusinesseducationOpioid substitution therapyDirect actingmedia_commonAddiction
researchProduct